https://www.thepeptidenewsroom.com/us-draft-policy-would-ease-access-to-six-peptides-but-none-are-fda-approved/ The Peptide Newsroom en 2026-11-02 US Draft Policy Would Ease Access to Six Peptides, But None Are FDA-Approved https://www.thepeptidenewsroom.com/midi-health-launches-compounded-sermorelin-but-a-critic-says-the-evidence-lags-t/ The Peptide Newsroom en 2026-11-02 Midi Health Launches Compounded Sermorelin, But a Critic Says the Evidence Lags the Marketing https://www.thepeptidenewsroom.com/kff-health-news-flags-four-misleading-peptide-claims-as-fda-weighs-looser-rules/ The Peptide Newsroom en 2026-11-02 KFF Health News Flags Four Misleading Peptide Claims as FDA Weighs Looser Rules https://www.thepeptidenewsroom.com/combined-sglt2-and-glp-1-therapy-linked-to-fewer-kidney-events-in-large-ckd-reco/ The Peptide Newsroom en 2026-11-02 Combined SGLT2 and GLP-1 Therapy Linked to Fewer Kidney Events in Large CKD Records Analysis https://www.thepeptidenewsroom.com/pharmather-targets-colon-with-3d-printed-kpv-and-bpc-157-but-the-evidence-is-pre/ The Peptide Newsroom en 2026-11-01 PharmaTher Targets Colon With 3D-Printed KPV and BPC-157, But the Evidence Is Preclinical https://www.thepeptidenewsroom.com/oxycodone-linked-to-higher-gut-risk-than-hydrocodone-in-glp-1-users-large-claims/ The Peptide Newsroom en 2026-11-01 Oxycodone Linked to Higher Gut Risk Than Hydrocodone in GLP-1 Users, Large Claims Study Finds https://www.thepeptidenewsroom.com/hhs-eases-enforcement-on-compounded-peptides-but-approval-is-not-what-changed/ The Peptide Newsroom en 2026-11-01 HHS Eases Enforcement on Compounded Peptides, But Approval Is Not What Changed https://www.thepeptidenewsroom.com/collagen-peptides-what-the-research-shows-on-skin-wounds-and-blood-pressure/ The Peptide Newsroom en 2026-11-01 Collagen Peptides: What the Research Shows on Skin, Wounds and Blood Pressure https://www.thepeptidenewsroom.com/bpc-157-use-rose-33-fold-in-clinical-records-but-the-evidence-has-not-followed/ The Peptide Newsroom en 2026-11-01 BPC-157 Use Rose 33-Fold in Clinical Records, But the Evidence Has Not Followed